United States Cholesterol-Lowering Drug Industry 2016 Deep Market Research Report
- QYR608297
- 137 Pages
- June 2016
- Pharmaceuticals
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Cholesterol-Lowering Drug market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.
Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Cholesterol-Lowering Drug industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.
With 145 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Industry Overview
1.1 Definition and Specifications of Cholesterol-Lowering Drug
1.1.1 Definition of Cholesterol-Lowering Drug
1.1.2 Specifications of Cholesterol-Lowering Drug
1.2 Classification of Cholesterol-Lowering Drug
1.3 Applications of Cholesterol-Lowering Drug
1.4 Industry Chain Structure of Cholesterol-Lowering Drug
1.5 Industry Overview of Cholesterol-Lowering Drug
1.6 Industry Policy Analysis of Cholesterol-Lowering Drug
1.7 Industry News Analysis of Cholesterol-Lowering Drug
2 Manufacturing Cost Structure Analysis of Cholesterol-Lowering Drug
2.1 Bill of Materials (BOM) of Cholesterol-Lowering Drug
2.2 BOM Price Analysis of Cholesterol-Lowering Drug
2.3 Labor Cost Analysis of Cholesterol-Lowering Drug
2.4 Depreciation Cost Analysis of Cholesterol-Lowering Drug
2.5 Manufacturing Cost Structure Analysis of Cholesterol-Lowering Drug
2.6 Manufacturing Process Analysis of Cholesterol-Lowering Drug
2.7 United States Price, Cost and Gross of Cholesterol-Lowering Drug 2011-2016
3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2015
3.2 Manufacturing Plants Distribution of United States Key Cholesterol-Lowering Drug Manufacturers in 2015
3.3 R&D Status and Technology Source of United States Cholesterol-Lowering Drug Key Manufacturers in 2015
3.4 Raw Materials Sources Analysis of United States Cholesterol-Lowering Drug Key Manufacturers in 2015
4 Production Analysis of Cholesterol-Lowering Drug by Regions, Type, and Applications
4.1 United States Production of Cholesterol-Lowering Drug by Regions 2011-2016
4.2 United States Production of Cholesterol-Lowering Drug by Type 2011-2016
4.3 United States Sales of Cholesterol-Lowering Drug by Applications 2011-2016
4.4 Price Analysis of United States Cholesterol-Lowering Drug Key Manufacturers in 2015
4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Cholesterol-Lowering Drug 2011-2016
5 Consumption Volume and Consumption Value Analysis of Cholesterol-Lowering Drug by Regions
5.1 United States Consumption Volume of Cholesterol-Lowering Drug by Regions 2011-2016
5.2 United States Consumption Value of Cholesterol-Lowering Drug by Regions 2011-2016
5.3 United States Consumption Price Analysis of Cholesterol-Lowering Drug by Regions 2011-2016
6 Analysis of Cholesterol-Lowering Drug Production, Supply, Sales and Market Status 2011-2016
6.1 Capacity, Production, Sales, and Revenue of Cholesterol-Lowering Drug 2011-2016
6.2 Production Market Share and Sales Market Share Analysis of Cholesterol-Lowering Drug 2014-2015
6.3 Sales Overview of Cholesterol-Lowering Drug 2011-2016
6.4 Supply, Consumption and Gap of Cholesterol-Lowering Drug 2011-2016
6.5 Import, Export and Consumption of Cholesterol-Lowering Drug 2011-2016
6.6 Cost, Price, Revenue and Gross Margin of Cholesterol-Lowering Drug 2011-2016
7 Analysis of Cholesterol-Lowering Drug Industry Key Manufacturers
7.1 AstraZeneca
7.1.1 Company Profile
7.1.2 Product Picture and Specifications
7.1.2.1 Type I
7.1.2.2 Type II
7.1.2.3 Type III
7.1.3 Capacity, Production, Price, Cost, Gross and Revenue
7.1.4 Contact Information
7.2 Merck
7.2.1 Company Profile
7.2.2 Product Picture and Specifications
7.2.2.1 Type I
7.2.2.2 Type II
7.2.2.3 Type III
7.2.3 Capacity, Production, Price, Cost, Gross and Revenue
7.2.4 Contact Information
7.3 Pfizer
7.3.1 Company Profile
7.3.2 Product Picture and Specifications
7.3.2.1 Type I
7.3.2.2 Type II
7.3.2.3 Type III
7.3.3 Capacity, Production, Price, Cost, Gross and Revenue
7.3.4 Contact Information
7.4 Kowa
7.4.1 Company Profile
7.4.2 Product Picture and Specifications
7.4.2.1 Type I
7.4.2.2 Type II
7.4.2.3 Type III
7.4.3 Capacity, Production, Price, Cost, Gross and Revenue
7.4.4 Contact Information
7.5 Daiichi Sankyo
7.5.1 Company Profile
7.5.2 Product Picture and Specifications
7.5.2.1 Type I
7.5.2.2 Type II
7.5.2.3 Type III
7.5.3 Capacity, Production, Price, Cost, Gross and Revenue
7.5.4 Contact Information
7.6 Abbvie
7.6.1 Company Profile
7.6.2 Product Picture and Specifications
7.6.2.1 Type I
7.6.2.2 Type II
7.6.2.3 Type III
7.6.3 Capacity, Production, Price, Cost, Gross and Revenue
7.6.4 Contact Information
7.7 Novartis
7.7.1 Company Profile
7.7.2 Product Picture and Specifications
7.7.2.1 Type I
7.7.2.2 Type II
7.7.2.3 Type III
7.7.3 Capacity, Production, Price, Cost, Gross and Revenue
7.7.4 Contact Information
7.8 Sanofi
7.8.1 Company Profile
7.8.2 Product Picture and Specifications
7.8.2.1 Type I
7.8.2.2 Type II
7.8.2.3 Type III
7.8.3 Capacity, Production, Price, Cost, Gross and Revenue
7.8.4 Contact Information
7.9 Amgen
7.9.1 Company Profile
7.9.2 Product Picture and Specifications
7.9.2.1 Type I
7.9.2.2 Type II
7.9.2.3 Type III
7.9.3 Capacity, Production, Price, Cost, Gross and Revenue
7.9.4 Contact Information
8 Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Cholesterol-Lowering Drug Product Types
8.5 Market Share Analysis of Different Cholesterol-Lowering Drug Price Levels
8.6 Gross Margin Analysis of Different Cholesterol-Lowering Drug Applications
9 Marketing Trader or Distributor Analysis of Cholesterol-Lowering Drug
9.1 Marketing Channels Status of Cholesterol-Lowering Drug
9.2 Traders or Distributors of Cholesterol-Lowering Drug with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Cholesterol-Lowering Drug
9.4 United States Import, Export and Trade Analysis of Cholesterol-Lowering Drug
10 Development Trend of Cholesterol-Lowering Drug Industry 2016-2021
10.1 Capacity and Production Overview of Cholesterol-Lowering Drug 2016-2021
10.2 Production Market Share by Product Types of Cholesterol-Lowering Drug 2016-2021
10.3 Sales and Sales Revenue Overview of Cholesterol-Lowering Drug 2016-2021
10.4 United States Sales of Cholesterol-Lowering Drug by Applications 2016-2021
10.5 Import, Export and Consumption of Cholesterol-Lowering Drug 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Cholesterol-Lowering Drug 2016-2021
11 Industry Chain Suppliers of Cholesterol-Lowering Drug with Contact Information
11.1 Major Raw Materials Suppliers of Cholesterol-Lowering Drug with Contact Information
11.2 Manufacturing Equipment Suppliers of Cholesterol-Lowering Drug with Contact Information
11.3 Major Players of Cholesterol-Lowering Drug with Contact Information
11.4 Key Consumers of Cholesterol-Lowering Drug with Contact Information
11.5 Supply Chain Relationship Analysis of Cholesterol-Lowering Drug
12 New Project Investment Feasibility Analysis of Cholesterol-Lowering Drug
12.1 New Project SWOT Analysis of Cholesterol-Lowering Drug
12.2 New Project Investment Feasibility Analysis of Cholesterol-Lowering Drug
13 Conclusion of the United States Cholesterol-Lowering Drug Industry 2016 Market Research Report
Figure Picture of Cholesterol-Lowering Drug
Table Product Specifications of Cholesterol-Lowering Drug
Table Classification of Cholesterol-Lowering Drug
Figure United States Sales Market Share of Cholesterol-Lowering Drug by Product Types in 2015
Table Applications of Cholesterol-Lowering Drug
Figure United States Sales Market Share of Cholesterol-Lowering Drug by Applications in 2015
Figure Industry Chain Structure of Cholesterol-Lowering Drug
Table United States Industry Overview of Cholesterol-Lowering Drug
Table Industry Policy of Cholesterol-Lowering Drug
Table Industry News List of Cholesterol-Lowering Drug
Table Bill of Materials (BOM) of Cholesterol-Lowering Drug
Table Bill of Materials (BOM) Price of Cholesterol-Lowering Drug
Table Labor Cost of Cholesterol-Lowering Drug
Table Depreciation Cost of Cholesterol-Lowering Drug
Table Manufacturing Cost Structure Analysis of Cholesterol-Lowering Drug in 2015
Figure Manufacturing Process Analysis of Cholesterol-Lowering Drug
Table United States Price Analysis of Cholesterol-Lowering Drug 2011-2016 (USD/Unit)
Table United States Cost Analysis of Cholesterol-Lowering Drug 2011-2016 (USD/Unit)
Table United States Gross Analysis of Cholesterol-Lowering Drug 2011-2016
Table Capacity (Unit) and Commercial Production Date of United States Cholesterol-Lowering Drug Key Manufacturers in 2015
Table Manufacturing Plants Distribution of United States Key Cholesterol-Lowering Drug Manufacturers in 2015
Table R&D Status and Technology Source of United States Cholesterol-Lowering Drug Key Manufacturers in 2015
Table Raw Materials Sources Analysis of United States and United States Cholesterol-Lowering Drug Key Manufacturers in 2015
Table United States Production of Cholesterol-Lowering Drug by Regions 2011-2016 (Unit)
Table United States Production Market Share of Cholesterol-Lowering Drug by Regions 2011-2016
Figure United States Production Market Share of Cholesterol-Lowering Drug by Regions in 2014
Figure United States Production Market Share of Cholesterol-Lowering Drug by Regions in 2015
Table United States Production of Cholesterol-Lowering Drug by Types in 2011-2016 (Unit)
Table United States Production Market Share of Cholesterol-Lowering Drug by Type in 2011-2016
Figure United States Production Market Share of Cholesterol-Lowering Drug by Type in 2014
Figure United States Production Market Share of Cholesterol-Lowering Drug by Type in 2015
Table United States Sales of Cholesterol-Lowering Drug by Applications 2011-2016 (Unit)
Table United States Production Market Share of Cholesterol-Lowering Drug by Applications 2011-2016
Figure United States Production Market Share of Cholesterol-Lowering Drug by Applications in 2014
Figure United States Production Market Share of Cholesterol-Lowering Drug by Applications in 2015
Table Price Comparison of United States Cholesterol-Lowering Drug Key Manufacturers in 2015 (USD/Unit)
Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Cholesterol-Lowering Drug 2011-2016
Table United States Consumption Volume of Cholesterol-Lowering Drug by Regions 2011-2016 (Unit)
Table United States Consumption Volume Market Share of Cholesterol-Lowering Drug by Regions 2011-2016
Figure United States Consumption Volume Market Share of Cholesterol-Lowering Drug by Regions in 2014
Figure United States Consumption Volume Market Share of Cholesterol-Lowering Drug by Regions in 2015
Table United States Consumption Value of Cholesterol-Lowering Drug by Regions 2011-2016 (M USD)
Table United States Consumption Value Market Share of Cholesterol-Lowering Drug by Regions 2011-2016
Figure United States Consumption Value Market Share of Cholesterol-Lowering Drug by Regions in 2014
Figure United States Consumption Value Market Share of Cholesterol-Lowering Drug by Regions in 2015
Table Consumption Price of Cholesterol-Lowering Drug by Regions 2011-2016 (USD/Unit)
Table United States and Major Manufacturers Capacity of Cholesterol-Lowering Drug 2011-2016 (Unit)
Table United States Capacity Market Share of Major Cholesterol-Lowering Drug Manufacturers 2011-2016
Table United States and Major Manufacturers Production of Cholesterol-Lowering Drug 2011-2016 (Unit)
Table United States Production Market Share of Major Cholesterol-Lowering Drug Manufacturers 2011-2016
Table United States and Major Manufacturers Sales of Cholesterol-Lowering Drug 2011-2016 (Unit)
Table United States Sales Market Share of Major Cholesterol-Lowering Drug Manufacturers 2011-2016
Table United States and Major Manufacturers Sales Revenue of Cholesterol-Lowering Drug 2011-2016 (M USD)
Table United States Sales Revenue Market Share of Major Cholesterol-Lowering Drug Manufacturers 2011-2016
Figure United States Capacity (Unit), Production (Unit) and Growth Rate of Cholesterol-Lowering Drug 2011-2016
Figure United States Capacity Utilization Rate of Cholesterol-Lowering Drug 2011-2016
Figure United States Sales Revenue (M USD) and Growth Rate of Cholesterol-Lowering Drug 2011-2016
Figure United States Production Market Share of Major Cholesterol-Lowering Drug Manufacturers in 2014
Figure United States Production Market Share of Major Cholesterol-Lowering Drug Manufacturers in 2015
Figure United States Sales Market Share of Major Cholesterol-Lowering Drug Manufacturers in 2014
Figure United States Sales Market Share of Major Cholesterol-Lowering Drug Manufacturers in 2015
Figure United States Sales (Unit) and Growth Rate of Cholesterol-Lowering Drug 2011-2016
Table United States Supply, Consumption and Gap of Cholesterol-Lowering Drug 2011-2016 (Unit)
Table United States Import, Export and Consumption of Cholesterol-Lowering Drug 2011-2016 (Unit)
Table Price of United States Cholesterol-Lowering Drug Major Manufacturers 2011-2016 (USD/Unit)
Table Gross Margin of United States Cholesterol-Lowering Drug Major Manufacturers 2011-2016
Table United States and Major Manufacturers Revenue of Cholesterol-Lowering Drug 2011-2016 (M USD)
Table United States Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Cholesterol-Lowering Drug 2011-2016
Table AstraZeneca Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Cholesterol-Lowering Drug Picture and Specifications of AstraZeneca
Table Cholesterol-Lowering Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of AstraZeneca 2011-2016
Figure Cholesterol-Lowering Drug Capacity (Unit), Production (Unit) and Growth Rate of AstraZeneca 2011-2016
Figure Cholesterol-Lowering Drug Production (Unit) and United States Market Share of AstraZeneca 2011-2016
Table AstraZeneca Cholesterol-Lowering Drug SWOT Analysis
Table Merck Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Cholesterol-Lowering Drug Picture and Specifications of Merck
Table Cholesterol-Lowering Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Merck 2011-2016
Figure Cholesterol-Lowering Drug Capacity (Unit), Production (Unit) and Growth Rate of Merck 2011-2016
Figure Cholesterol-Lowering Drug Production (Unit) and United States Market Share of Merck 2011-2016
Table Merck Cholesterol-Lowering Drug SWOT Analysis
Table Pfizer Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Cholesterol-Lowering Drug Picture and Specifications of Pfizer
Table Cholesterol-Lowering Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Pfizer 2011-2016
Figure Cholesterol-Lowering Drug Capacity (Unit), Production (Unit) and Growth Rate of Pfizer 2011-2016
Figure Cholesterol-Lowering Drug Production (Unit) and United States Market Share of Pfizer 2011-2016
Table Pfizer Cholesterol-Lowering Drug SWOT Analysis
Table Kowa Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Cholesterol-Lowering Drug Picture and Specifications of Kowa
Table Cholesterol-Lowering Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Kowa 2011-2016
Figure Cholesterol-Lowering Drug Capacity (Unit), Production (Unit) and Growth Rate of Kowa 2011-2016
Figure Cholesterol-Lowering Drug Production (Unit) and United States Market Share of Kowa 2011-2016
Table Kowa Cholesterol-Lowering Drug SWOT Analysis
Table Daiichi Sankyo Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Cholesterol-Lowering Drug Picture and Specifications of Daiichi Sankyo
Table Cholesterol-Lowering Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Daiichi Sankyo 2011-2016
Figure Cholesterol-Lowering Drug Capacity (Unit), Production (Unit) and Growth Rate of Daiichi Sankyo 2011-2016
Figure Cholesterol-Lowering Drug Production (Unit) and United States Market Share of Daiichi Sankyo 2011-2016
Table Daiichi Sankyo Cholesterol-Lowering Drug SWOT Analysis
Table Abbvie Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Cholesterol-Lowering Drug Picture and Specifications of Abbvie
Table Cholesterol-Lowering Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Abbvie 2011-2016
Figure Cholesterol-Lowering Drug Capacity (Unit), Production (Unit) and Growth Rate of Abbvie 2011-2016
Figure Cholesterol-Lowering Drug Production (Unit) and United States Market Share of Abbvie 2011-2016
Table Abbvie Cholesterol-Lowering Drug SWOT Analysis
Table Novartis Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Cholesterol-Lowering Drug Picture and Specifications of Novartis
Table Cholesterol-Lowering Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Novartis 2011-2016
Figure Cholesterol-Lowering Drug Capacity (Unit), Production (Unit) and Growth Rate of Novartis 2011-2016
Figure Cholesterol-Lowering Drug Production (Unit) and United States Market Share of Novartis 2011-2016
Table Novartis Cholesterol-Lowering Drug SWOT Analysis
Table Sanofi Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Cholesterol-Lowering Drug Picture and Specifications of Sanofi
Table Cholesterol-Lowering Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Sanofi 2011-2016
Figure Cholesterol-Lowering Drug Capacity (Unit), Production (Unit) and Growth Rate of Sanofi 2011-2016
Figure Cholesterol-Lowering Drug Production (Unit) and United States Market Share of Sanofi 2011-2016
Table Sanofi Cholesterol-Lowering Drug SWOT Analysis
Table Amgen Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Cholesterol-Lowering Drug Picture and Specifications of Amgen
Table Cholesterol-Lowering Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Amgen 2011-2016
Figure Cholesterol-Lowering Drug Capacity (Unit), Production (Unit) and Growth Rate of Amgen 2011-2016
Figure Cholesterol-Lowering Drug Production (Unit) and United States Market Share of Amgen 2011-2016
Table Amgen Cholesterol-Lowering Drug SWOT Analysis
Table Cholesterol-Lowering Drug Price by Regions 2011-2016
Table Cholesterol-Lowering Drug Price by Product Types 2011-2016
Table Cholesterol-Lowering Drug Price by Companies 2011-2016
Table Cholesterol-Lowering Drug Gross Margin by Companies 2011-2016
Table Price Comparison of Cholesterol-Lowering Drug by Regions 2011-2016 (USD/Unit)
Table Price of Different Cholesterol-Lowering Drug Product Types (USD/Unit)
Table Market Share of Different Cholesterol-Lowering Drug Price Level
Table Gross Margin of Different Cholesterol-Lowering Drug Applications
Table Marketing Channels Status of Cholesterol-Lowering Drug
Table Traders or Distributors of Cholesterol-Lowering Drug with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Cholesterol-Lowering Drug (USD/Unit) in 2015
Table United States Import, Export, and Trade of Cholesterol-Lowering Drug (Unit)
Figure United States Capacity (Unit), Production (Unit) and Growth Rate of Cholesterol-Lowering Drug 2016-2021
Figure United States Capacity Utilization Rate of Cholesterol-Lowering Drug 2016-2021
Table United States Cholesterol-Lowering Drug Production by Type 2016-2021 (Unit)
Table United States Cholesterol-Lowering Drug Production Market Share by Type 2016-2021
Figure United States Production Market Share of Cholesterol-Lowering Drug by Type in 2021
Figure United States Sales (Unit) and Growth Rate of Cholesterol-Lowering Drug 2016-2021
Figure United States Sales Revenue (Million USD) and Growth Rate of Cholesterol-Lowering Drug 2016-2021
Figure United States Sales of Cholesterol-Lowering Drug by Applications 2016-2021 (Unit)
Table United States Production Market Share of Cholesterol-Lowering Drug by Applications 2016-2021
Figure United States Production Market Share of Cholesterol-Lowering Drug by Applications in 2021
Table United States Production, Import, Export and Consumption of Cholesterol-Lowering Drug 2016-2021 (Unit)
Table United States Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Cholesterol-Lowering Drug 2016-2021
Table Major Raw Materials Suppliers of Cholesterol-Lowering Drug with Contact Information
Table Manufacturing Equipment Suppliers of Cholesterol-Lowering Drug with Contact Information
Table Major Players of Cholesterol-Lowering Drug with Contact Information
Table Key Consumers of Cholesterol-Lowering Drug with Contact Information
Table Supply Chain Relationship Analysis of Cholesterol-Lowering Drug
Table New Project SWOT Analysis of Cholesterol-Lowering Drug
Table New Project Investment Feasibility Analysis of Cholesterol-Lowering Drug
Table Part of Interviewees Record List
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
